• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-30c通过靶向转移相关基因1抑制卵巢癌转移。

MicroRNA-30c inhibits metastasis of ovarian cancer by targeting metastasis-associated gene 1.

作者信息

Wang Xia, Qiu Li-Wei, Peng Chen, Zhong Shu-Ping, Ye Lin, Wang Di

机构信息

Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.

Clinical Medicine Research Centre, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.

出版信息

J Cancer Res Ther. 2017;13(4):676-682. doi: 10.4103/jcrt.JCRT_132_17.

DOI:10.4103/jcrt.JCRT_132_17
PMID:28901313
Abstract

BACKGROUND

It is important to find reliable molecular markers or biological targets that associate with ovarian cancer (OC) metastasis for diagnosis and treatment. In this study, researchers investigated the regulated chain of microRNA-30c (miR-30c) and metastasis-associated gene 1 (MTA1) in OC tissues and cells.

MATERIALS AND METHODS

Expression of miR-30c and MTA1 was detected with quantitative real-time polymerase chain reaction and immunohistochemistry in 33 OC and matched adjacent tissues. MiR-30c mimics were synthetized and transfected into SKOV3 cells to target MTA1. The wound healing and transwell assays were detected to observe migration and invasion of transfected OC cells.

RESULTS

Compared with matching normal ovarian tissues, the MTA1 expression was upregulated and localized in the cytoplasm, and the expression of miR-30c was significantly reduced. The expression intensity of MTA1 was correlated with the Federation of Gynecology and Obstetrics stage, tumor grade, and metastasis of OC. Transfecting miR-30c mimics could significantly reduce the expression of MTA1 in SKOV3 cells and obviously inhibit the migration and invasion of SKOV3 cells.

CONCLUSION

MiR-30c and MTA1 abnormally expressed in OC, which may be related to metastasis of OC. In MiR-30c as a tumor suppressor gene, its expression in OC could lead to reduced expression of MTA1, which may be one of the mechanisms of metastasis of OC cells.

摘要

背景

寻找与卵巢癌(OC)转移相关的可靠分子标志物或生物学靶点对于诊断和治疗至关重要。在本研究中,研究人员调查了OC组织和细胞中微小RNA-30c(miR-30c)和转移相关基因1(MTA1)的调控链。

材料与方法

采用定量实时聚合酶链反应和免疫组织化学检测33例OC组织及配对的相邻组织中miR-30c和MTA1的表达。合成miR-30c模拟物并转染到SKOV3细胞中以靶向MTA1。通过伤口愈合试验和Transwell试验检测转染后的OC细胞的迁移和侵袭能力。

结果

与配对的正常卵巢组织相比,MTA1表达上调且定位于细胞质中,而miR-30c的表达显著降低。MTA1的表达强度与国际妇产科联盟(FIGO)分期、肿瘤分级及OC转移相关。转染miR-30c模拟物可显著降低SKOV3细胞中MTA1的表达,并明显抑制SKOV3细胞的迁移和侵袭。

结论

miR-30c和MTA1在OC中异常表达,这可能与OC转移有关。作为肿瘤抑制基因的miR-30c在OC中的表达可导致MTA1表达降低,这可能是OC细胞转移的机制之一。

相似文献

1
MicroRNA-30c inhibits metastasis of ovarian cancer by targeting metastasis-associated gene 1.微小RNA-30c通过靶向转移相关基因1抑制卵巢癌转移。
J Cancer Res Ther. 2017;13(4):676-682. doi: 10.4103/jcrt.JCRT_132_17.
2
microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1.microRNA-30c 通过靶向转移相关基因-1 负调控子宫内膜癌细胞。
Oncol Rep. 2012 Mar;27(3):807-12. doi: 10.3892/or.2011.1574. Epub 2011 Dec 1.
3
MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.miR-30c-5p 通过靶向 MTA1 抑制胃癌的迁移、侵袭和上皮间质转化。
Biomed Pharmacother. 2017 Sep;93:554-560. doi: 10.1016/j.biopha.2017.06.084. Epub 2017 Jul 4.
4
Metastasis-associated protein 1, modulated by miR-30c, promotes endometrial cancer progression through AKT/mTOR/4E-BP1 pathway.转移相关蛋白 1 通过 miR-30c 调节,通过 AKT/mTOR/4E-BP1 通路促进子宫内膜癌的进展。
Gynecol Oncol. 2019 Jul;154(1):207-217. doi: 10.1016/j.ygyno.2019.04.005. Epub 2019 Apr 9.
5
Down-regulation of miR-30c promotes the invasion of non-small cell lung cancer by targeting MTA1.miR-30c的下调通过靶向MTA1促进非小细胞肺癌的侵袭。
Cell Physiol Biochem. 2013;32(2):476-85. doi: 10.1159/000354452. Epub 2013 Aug 27.
6
Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.微小RNA-183通过靶向MTA1对人胰腺癌SW1900细胞上皮-间质转化、增殖、迁移、侵袭及凋亡的影响
Exp Mol Pathol. 2017 Jun;102(3):522-532. doi: 10.1016/j.yexmp.2017.05.009. Epub 2017 May 12.
7
MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.MiR-183过表达通过靶向鼻咽癌中的MTA1抑制肿瘤发生并增强顺铂诱导的细胞毒性。
Tumour Biol. 2017 Jun;39(6):1010428317703825. doi: 10.1177/1010428317703825.
8
LINC01342 promotes the progression of ovarian cancer by absorbing microRNA-30c-2-3p to upregulate HIF3A.LINC01342 通过吸收 microRNA-30c-2-3p 来上调 HIF3A 促进卵巢癌的进展。
J Cell Physiol. 2020 Apr;235(4):3939-3949. doi: 10.1002/jcp.29289. Epub 2019 Oct 9.
9
miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion.微小RNA-125a-3p靶向转移相关蛋白1以抑制非小细胞肺癌细胞的增殖、迁移和侵袭。
Acta Biochim Biophys Sin (Shanghai). 2015 Jul;47(7):496-503. doi: 10.1093/abbs/gmv039. Epub 2015 May 21.
10
Overexpression of MTA1 promotes invasiveness and metastasis of ovarian cancer cells.MTA1 的过表达促进了卵巢癌细胞的侵袭和转移。
Ir J Med Sci. 2014 Sep;183(3):433-8. doi: 10.1007/s11845-013-1034-7. Epub 2013 Nov 10.

引用本文的文献

1
Identification of miR-30c-5p microRNA in Serum as a Candidate Biomarker to Diagnose Endometriosis.鉴定血清中的 miR-30c-5p 微小 RNA 作为诊断子宫内膜异位症的候选生物标志物。
Int J Mol Sci. 2024 Feb 3;25(3):1853. doi: 10.3390/ijms25031853.
2
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.中国卵巢癌患者体细胞改变的综合分析。
Sci Rep. 2021 Jan 11;11(1):387. doi: 10.1038/s41598-020-79694-0.
3
Molecular characterization of carcinosarcomas arising in the uterus and ovaries.子宫和卵巢发生的癌肉瘤的分子特征
Oncotarget. 2019 Jun 4;10(38):3614-3624. doi: 10.18632/oncotarget.26942.
4
miR-30c Impedes Glioblastoma Cell Proliferation and Migration by Targeting SOX9.miR-30c 通过靶向 SOX9 抑制胶质母细胞瘤细胞的增殖和迁移。
Oncol Res. 2019 Feb 5;27(2):165-171. doi: 10.3727/096504018X15193506006164. Epub 2018 Mar 1.